Effectiveness of BCG
Vaccination Against Tuberculous Meningits |
Shally A wasthi and Soofia Moin
From the Department of Pediatrics, King George's Medical College, Lucknow (UP), India.
Reprint requests: Dr. Shally Awasthi, C-4, Officer's Colony, Niralanagar, Lucknow
226 020, UP, India.
E-mail: [email protected]
Manuscript received: May 22, 1998; Initial review completed: July 27,
1998;
Revision accepted: November 19, 1998.
Abstract:
Objective: To assess the protective effectiveness of BCG vaccination against tuberculous meningitis, while controlling for age, nutrition and socio-economic status, in children
1 month to 12 years of age. Design: Case-control study. Setting: Secondary care referral and teaching hospital.
Methods: Cases were those conforming to the definition of tuberculous meningitis and controls were patients admitted after every third consecutive case included in the study from September 1995 till the end of August
1997 and who did not suffer from any central nervous system disorder. Results: Among the
192 cases and 70 controls, BCG scar was present in 57.8% and 75.7%, respectively. The crude odd's ratio (OR) for tuberculosis meningitis with a BCG scar was 0.44 (95% CI, .24-0.81; p=0.008), while the adjusted OR was 0.53 (95% C/, 0.26-1.06; p value
=
0.07) after controlling for weight, age, sex and place of residence. Higher weight for age and urban residence were associated with a decreased risk of tuberculous meningitis in the logistic model.
Conclusion: BCG vaccination offers protection against tuberculous meningitis. Since improvement in weight for age was associated with a decreased risk of disease, further studies are needed to evaluate the association, if any, between nutritional status and vaccine efficacy.
Key words: BCG vaccine, Protective efficacy, Tuberculous meningitis.
TUBERCULOUS meningitis is an important
cause of hospital admission in the developing countries(1). Studies have found BCG vaccination to be protective against tuberculous
meningitis and disseminated tuberculosis(2-9). However, in most of
the studies confounding by age, nutritional or socio-economic status could not be effectively analyzed, often due to overmatching of cases and control with
reference to these variables. The current work was undertaken to
study the protective efficacy of BCG vaccination, if any,
controlling for age, sex, weight and other immunization and socio-economic status.
Subjects and Methods
The study was conducted among children between 1 month to 12 years of age admitted in the Pediatrics Department of King George's Medical College, Lucknow, from September 1995 till the end of August 1997. Among patients presenting with the symptom complex of fever, headache or irritability, with or without vomiting, and either altered sensorium or
first episode of seizures or both, tuberculous meningitis was defined as: (i) the presence of all three of the following cerebrospinal fluid abnormalities (if lumbar puncture
could be done): leukocytosis > 10 and <1000 X 106 cells/L, predominantly lymphocytes (>80%), proteins
≥60 mg/L with or without CSF glucose > 1.66 mmol/L (>30 mg/dL) and cerebro-spinal fluid culture sterile for pyogenic bacteria or (ii) if lumbar puncture was not done, treatment as tuberculous basal meningitis with at least 4 antitubercular drugs with no other concurrent antibiotics. Every patient admitted after third consecutive cases was a control, if he/she did not suffer from any disorder of the central nervous system and whose parents gave consent for the study. While the tentative diagnosis of the control at the
time of admission was noted, the diagnosis at the time of discharge or death was considered as final.
Sample size calculations were based on reported crude odd's ratio of 0.36 (95% CI 0.19- 0.70) for tuberculous meningitis given a BCG scar in children less than 5 years of age from
India (1). With a 0.3 ratio of controls to cases an odd's ratio of 0.5 with 70% prevalence of BCG scar in the controls and an alpha of 0.05 and power of,0.8, the estimated number of cases and controls was 138 and 42, respectively, using Epi
Info 6.0 statistical software(10). A 0.3 ratio of cases to controls was taken to maximize on power(11) and at the same time have efficient data collection.
Data was collected on the age, sex, immunization and socio-economic status, including the family income, as well as the number of doses of vitamin A taken. Weight and height of the children and their parents was also taken. The Epi Info 6.0 statistical software was used to calculate the z-scores for weight for age (10). Based on the WHO classification, children were classified as underweight when the z score for weight for age was <-2.00(10). Presence of BCG
scar on the insertion of the left deltoid muscle was noted. Results of the following investigations, if
done, were noted in all the cases: computerized axial tomographic scan (CTS) of the head, chest roentgenogram (postero-anterior view), fundoscopy and BCG
diagnostic testing. The BCG diagnostic test was interpreted as positive if a papule with an induration of >5 mm appeared within 24 to 48 hours(12). Chest roentgenograms were performed within the first 72 hours and CT scans within the first ten days of hospitalization. Both of these investigations, when done, were ordered as a part of routine patient care by the physician in charge of the case.
Univariate analysis was done to study the distribution of various variables as
well as to compare them among the cases and the controls. Univariate association between BCG scar and meningitis was done by calculating the crude odd's ratio with 95% confidence interval (CI). Logistic regression was done using STATA software(13) to find the association of tuberculous meningitis with BCG scar, while controlling for those variable that were found to have univariate association between the case-control status and were clinically meaningful.
Results
There were 192 cases and 70 controls. The diagnostic category of controls was as follows: diarrheal diseases (n=15, 21.4%), respi- ratory diseases (n=16, 22.9%), hematological diseases (n=7, 10%), renal diseases (n=9, 12.9%), hepatobiliary diseases (n=6, 8.6%), malnutrition (n=4, 5.7%), genetic/immune (n=6, 8.6%) and others (n=7, 10%). There was 16 deaths in the cases and none in the controls.
The diagnosis of tuberculous meningitis was based on cerebrospinal fluid examination in 179 (93.2%) cases. In the 13 cases (6.8%) where CSF examination could not be done, CT scan was done and there were abnormalities like basal exudates (n=8), ventricular
dilatation (n=7) and meningeal enhancement (n=10). Since the CT scan findings
were supportive of the diagnosis of tuberculous meningitis, these cases have been included in all analysis.
CT scan (brain) was done in 141 (80.1 %) of the 176 survivors. CT scan was normal in (n=7) 5% cases. The abnormalities found were basal exudates (n=87) in 61.7%, ventricular dilatation in (n=101) 71.6%, obstructive hydrocephalus in (n=56) 39.7%, cerebral edema in 3, and tuberculoma and hypodense areas in 1 case each. Fundus examination was done in all 192 cases and showed a normal optic disc and retina in 115 (59.9%), pallor in 31 (16.1%), papilledema in 29 (15.1%), hyperemia in 8 (4.2%) and optic atrophy in 9 (4.7%). Chest roentgenograms were taken for '170 cases and was interpreted as normal in 62 (36.5%) and showed abnormalities suggestive of pulmonary tuberculosis in 108 (63.5%) cases. The positive X-ray findings were primary
complex (which included either presence of parenchymal or lymph node
enlargement or both) in 84.3% (n=9l), bronchopneumonia in 9.3% (n=IO), consolidation in 3.7% (n=4) and miliary tuberculosis in 2.8% (n=3). BCG diagnostic test was done in 170 cases and was positive in 51 (30%).
The anthropometric, immunization and socio-economic characteristic of cases and controls has been compared in Table I. Cases were younger in age, had higher proportion of underweight and lower proportion of immunized children when compared to the controls (Table I).
Two-thirds cases and 47.1 % controls were from the rural areas. Among the children coming from rural and urban areas 59% and 58%, respectively, were immunized with 3 doses of DPT/OPV and 61.5% and 65%, respectively, had a BCG scar. There was no association between immunization with 3 doses of DPT/OPV and residence in a rural
area (Chi square
=
0.44, P value
=
0.6). The crude odds' ratio for tuberculous meningitis in children with a BCG scar was 0.44 (95% CI 0.24-0.81; P
=
0.008). The prevented proportion of cases of tuberculous meningitis with a BCG scar was 56.04% (95% CI, 18.96%- 76.13% ).
The results of the logistic regression to assess the association between tuberculosis and BCG scar is given in Table ll.
The adjusted
odd's ratio for tuberculous meningitis given a
BCG scar was 0.53 (95% CI, 0.26 to 1.06; p
=
0.07), while controlling for age, weight, sex and place of residence (Table II).
Discussion
This was a hospital based case-control study. We observed that the
association between the presence of BCG scar and tuberculous meningitis is confounded by age and weight, and place of residence (rural) is an in- dependent risk factor for it. On controlling for these, the risk reduction of tuberculous meningitis by BCG vaccination could not be proved beyond the accepted limits of chance.
On univariate analysis, we found a 56.04% (95% CI: 18.9%-76.1 %) protective efficacy of BCG against tuberculous meningitis. This is less than the 80.2% efficacy reported from Sao Paulo, with hospital controls(2)
and 100% from Argentina(3) but in accordance with unclear protective
efficacy reported from India in the past(14). We also observed that
controlling for confounders resulted in a reduction in the protective efficacy of the vaccine. In fact, studies from Sao Paulo and Argentina have not controlled for these in their published analyses.
We did not match the controls with the age and sex of the cases.
Hence the cases of tuberculous meningitis were younger and weighed less than the cases (Table l). The difference in
TABLE I
Characteristics of Cases and Controls
Variable |
Case |
Control |
p value |
Number |
192 |
70 |
|
Male |
115 (59.9%) |
44 (62.9%) |
0.7 |
Age (mo) |
46.1 :t 35.8 |
66.9 :t 45.8 |
0.003 |
Weight (kg) |
10.1 :t 4.6 |
15.5 :t 8.4 |
<0.0001 |
Height (cm) |
90.7:t 22.1 |
103.6:t 27.3 |
0.001 |
Underweight |
169 (88%) |
40 (57.1 %) |
<0.0001 |
Immunization status |
DPT/OPV (3 doses) |
101 (52.6%) |
51 (72.9%) |
0.01 |
Vitamin A (1 +) |
100(52.1%) |
48 (68.6%) |
<0.01 |
BCG scar |
III (57.8%) |
53 (75.7%) |
0.01 |
SE Status |
# Rural |
128 (66.7%) |
33(47.1%) |
0.004
|
Income (Rs.)
|
1765
:t
694
|
1991
:t
799
|
0.1
|
# I room house |
153 (79.7%) |
54 (77.1 %) |
0.6 |
Height (Father) |
158.4 :t 3.8 |
159.3 :t 4 |
0.09 |
Height (Mother) |
153.1 :t 3.6 |
153.3 :t 3.4 |
0.5 |
TABLE II
Results of Logistic Regression Assessing the Association of Tuber cillo us Meninigitis with BCG Scar.
Variable
|
Adjsted OR |
95% CI |
P value |
Coding |
BCG Scar |
0.53 |
0.26 to 1.06 |
0.07 |
I =Yes,O=No |
Weight (Kg) |
0.80 |
0.72 to 0.99 |
<0.0001 |
Continuous |
Age (mths) |
0.98 |
0.97 to 0.99 |
0.06 |
Continuous |
Sex |
0.95 |
0.49 to 1.84 |
0.9 |
1
=
Male, 0
=
Female
|
Rural
|
2.36 |
1.26 to 4.44 |
0.007 |
1
=
Rural, 0
=
Urban
|
Constant
|
18.54 |
4.31 to 79.04 |
<0.0001 |
|
Number of observations
=
262; chi2(5)
=
60.87, p value
=
<0.00001; Log likelihood =-121.64.
their weights may be an underestimation due to fluid retention in a few controls We could, therefore, study the effect of age, weight and sex on the protective efficacy of BCG scar against tuberculous meningitis and have con- trolled for this imbalance in the analysis. We found that for children with BCG scar, increased weight for age for both the sexes was associated with a lower risk of tuberculous meningitis.
It is known that the vaccine efficacy is altered by the nutritional, genetic and immuno- logical make up of the subjects(15,16). The in fluency of ethnicity on the protective efficacy of BCG vaccination against tuberculous meningitis needs to be studied further. The association of weight for age with tuberculous meningitis is feasible since children with lower weight-for-age are at increased risk of mortality due to infectious diseases( 17). In addition, we have found that children living in rural areas have an increased risk of tuberculous meningitis.
Since there was no difference in the proportions who had a BCG scar on the basis of the place of residence, the reasons for the reduced protective efficacy of BCG scar in rural children need to be deter- mined. Possible explanations for this phenomenon may be an increased exposure to adult cases of tuberculosis in rural as compared to urban areas, poor ventilation and undetermined environmental factors.
The strengths of this study are in its case- control design and
random selection of controls that allowed study of confounding with age, weight and sex. The weaknesses are in taking BCG scar as a surrogate marker of immune response to vaccination, whereas this may not always be true. Since making the diagnosis of tuberculous meningitis is not always foolproof, there may have been misclassification with other types of meningitis which may have biased the results towards null. This drawback of disease classification, however, has been present in most studies on this issue.
Since an association between BCG vaccination and tuberculous meningitis was found with and without controlling for known con- founders, we conclude that BCG vaccination is preventive against tuberculous meningitis. Also, since increased weight for age was found to be associated with a decreased risk of disease, further studies are needed to find the association between nutritional status and vaccine efficacy. Factors associated with an increased risk of tuberculous meningitis in the rural children in India have to be identified.
Acknowledgments
This work was partly funded by a grant from the UP State Council for Science and Technology (CST). The computing facilities used have been provided by the International Clinical Epidemiology Network (INCLEN),
USA and Clinical Trials Service Unit (CTSU), Oxford, UK.
|
1.
Mittal SK, Aggarwal V, Rastogi A, Saini N. Does BCG vaccination prevent or postpone the occurrence of tuberculous
meningitis? Indian J Pediatr 1996; 63: 659-664.
2.
Filho VW, de Castilho EA, Rodirigues LC, Huttly SRA. Effectiveness of BCG vaccination against tuberculous meningitis: 2-year case-control study in Sao Paulo, Brazil. Bull WHO 1990; 68: 69-74.
3.
Micel I, de-Kantor IN, Colaiacovo D, Peluffo G, Cutillo I, Gorra R. et al. Evaluation of the effectiveness of BCG vaccination using the case-control method in Buenos Aires, Argentina. Int J Epid, 1988; 17: 629-634.
4.
Smith PG. Case-control studies of the efficacy of BCG vaccine in children. Bull Intn Union Tub Lung Dis 1987; 625: 70-76.
5.
Smith PG. Retrospective assessment of the effectiveness of BCG vaccination
against tuberculosis using the case-control method. Tubercle 1982; 63: 23-35.
6.
Medical Research Council Tuberculosis Vaccines Clinical Trials Committee. BCG and Vole bacillus vaccines in the prevention of tuberculosis in adolescents. First Report. BMJ 1956; I: 413-427.
7.
Medical Research Council Tuberculosis Vaccines Clinical Trials Committee. BCG and Vole bacilus vaccines in the prevention of tuberculosis in adolescence and early adult life. Third Report. BMJ 1963; 1: 973-978.
8.
Medical Research Council Tuberculosis Vac- cines Clinical Trials Committee. BCG and Vole bacilus vaccines in the prevention of tuberculosis in adolescence and early adult life. Fourth Report. Bull WHO, 1972; 46: 371- 385.
9.
Aneja KS. Immunoprophylaxis in tuberculo- sis. J Comm Dis 1983; 16: 49-53.
10.
Epi-Info 6. Center for Disease Control and Prevention. USA and World Health Organization, Geneva, Switzerland. 1994.
11.
Hennekens CH, Buring JE. Case Control studies. In: Epidemiology in Medicine. Ed Mayrent SL. Boston. Little, Brown and Com- pany, 1987; pp 132-145.
12.
Udani PM, Parikh UC, Shah PM, Naik'PA. BCG test in tuberculosis. Indian Pediatr 1971; 8: 143-150.
13.
Stata Reference Manual, Release 3.1, Volume 3: 6 edn. College Station, Texas, Stata Corpo- ration, 1993.
14.
Indian Medical Research Council Tuberculosis Prevention Trial, Madras. Trial of BCG
vaccine in South India J. Med Res, 1980; 72 (suppl): 1-74.
vaccine in South India. Indian J Med Res, 1980; 72 (Suppl): 1-74.
15.
Chaparas SD. Immunity in tuberculosis. Bull WHO 1982; 60: 447-462.
16.
Clemens: JD, Choung JJ, Feinstein AR. The BCG controversy. JAM A 1983; 17: 2362- 2369.
17.
Kielman AA, Taylor CE, Mc Sweemer C, Uberoi IS, Takulia HS, Masih N, et al. The Narangwal experiment on interaction of nutrition and infections - II. Morbidity, mortality and effects. Indian J Med Res 1978; 68 (Suppl): 21-41.
|